Diagnostic Vitrectomy and the Cancer Patient: Special Considerations

  • Garvin H. DavisEmail author
  • Gibran S. Khurshid
  • Kapil G. Kapoor
  • Bernard F. Godley
Part of the M.D. Anderson Solid Tumor Oncology Series book series (MDA, volume 6)


The term diagnostic vitrectomy is used to refer to biopsy of the vitreous or the uvea. In patients with a history of cancer, there is a low clinical threshold for diagnostic vitrectomy as vitritis can represent recurrence of lymphoma or leukemia or an opportunistic infection. The most common clinical scenarios in which diagnostic vitrectomy is performed in cancer patients are new-onset vitreous cellularity in a patient with lymphoma in remission or newly diagnosed lymphoma; vitritis in a patient with recent bone marrow transplantation; atypical retinitis or choroiditis; and atypical iris, ciliary body, or choroidal lesions. In addition, choroidal biopsy is sometimes done to obtain material for cytogenetic studies in patients with uveal melanoma. Vitreous biopsy can be performed successfully with either a two-port or three-port approach; specifics of the technique depend on the vitrector gauge. Uveal biopsy can be performed with fine-needle aspiration biopsy or with transretinal choroidal biopsy with a sutureless vitrectomy system, an approach that is gaining favor. Collaboration and good communication between the ophthalmologist and a pathologist well versed in the handling and analysis of vitreous samples are essential for successful diagnostic vitrectomy.


Uveal Melanoma Vitreous Hemorrhage Central Nervous System Lymphoma Vitreous Sample Endogenous Endophthalmitis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Robertson DM, Wilkinson CP, Murray JL, et al. Metastatic tumor to the retina and vitreous cavity from primary melanoma of the skin: treatment with systemic and subconjunctival chemotherapy. Ophthalmology 1981;88(12):1296–1301.PubMedGoogle Scholar
  2. 2.
    Jaissle GB, Szurman P, Rohrbach JM, et al. A case of cutaneous melanoma metastatic to the vitreous cavity: possible pathomechanism and review of the literature. Graefes Arch Clin Exp Ophthalmol 2007;245(5):733–40.PubMedCrossRefGoogle Scholar
  3. 3.
    Soheilian M, Mirbabai F, Shahsavari M, et al. Metastatic cutaneous melanoma to the vitreous cavity masquerading as intermediate uveitis. Eur J Ophthalmol 2002;12(4):324–7.PubMedGoogle Scholar
  4. 4.
    Greene WH, Wiernik PH. Candida endophthalmitis. Successful treatment in a patient with acute leukemia. Am J Ophthalmol 1972;74(6):1100–4.PubMedGoogle Scholar
  5. 5.
    Rogers SJ, Johnson BL. Endogenous Nocardia endophthalmitis: report of a case in a patient treated for lymphocytic lymphoma. Ann Ophthalmol 1977;9(9):1123–31.PubMedGoogle Scholar
  6. 6.
    Lamaris GA, Esmaeli B, Chamilos G, et al. Fungal endophthalmitis in a tertiary care cancer center: a review of 23 cases. Eur J Clin Microbiol Infect Dis 2008;27(5):343–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Engel HM, Green WR, Michels RG, et al. Diagnostic vitrectomy. Retina 1981;1(2):121–49.PubMedCrossRefGoogle Scholar
  8. 8.
    Green WR. Diagnostic cytopathology of ocular fluid specimens. Ophthalmology 1984;91(6):726–49.PubMedGoogle Scholar
  9. 9.
    Davis JL, Miller DM, Ruiz P. Diagnostic testing of vitrectomy specimens. Am J Ophthalmol 2005;140(5):822–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Foulds WS. The uses and limitations of intraocular biopsy. Eye 1992;6(Pt 1):11–27.PubMedCrossRefGoogle Scholar
  11. 11.
    Saro F, Clua A, Esteva E, et al. Cytologic diagnosis of ocular melanocytoma: a case report. Acta Cytol 2008;52(1):87–90.PubMedCrossRefGoogle Scholar
  12. 12.
    Landreville S, Agapova OA, Harbour JW. Emerging insights into the molecular pathogenesis of uveal melanoma. Future Oncol 2008;4:629–36.PubMedCrossRefGoogle Scholar
  13. 13.
    Rosenfeld SI, Litinsky SM, Snyder DA, et al. Effectiveness of monitored anesthesia care in cataract surgery. Ophthalmology 1999;106(7):1256–60; discussion 1261.PubMedCrossRefGoogle Scholar
  14. 14.
    Papamatheakis DG, Demers P, Vachon A, et al. Thrombocytopenia and the risks of intraocular surgery. Ophthalmic Surg Lasers Imaging 2005;36(2):103–7.PubMedGoogle Scholar
  15. 15.
    Saeed MU, Wong D, Heimann H, et al. Spontaneous progressive supra-choroidal haemorrhage in a patient undergoing haemodialysis. Graefes Arch Clin Exp Ophthalmol 2007;245(11):1741–2.PubMedCrossRefGoogle Scholar
  16. 16.
    Hamilton RC. Retrobulbar block revisited and revised. J Cataract Refract Surg 1996;22(9):1147–50.PubMedGoogle Scholar
  17. 17.
    Duker JS. Retrobulbar injections: standards of care. Surv Ophthalmol 1995;39(4):344–5.PubMedCrossRefGoogle Scholar
  18. 18.
    Demediuk OM, Dhaliwal RS, Papworth DP, et al. A comparison of peribulbar and retrobulbar anesthesia for vitreoretinal surgical procedures. Arch Ophthalmol 1995;113(7):908–13.PubMedCrossRefGoogle Scholar
  19. 19.
    Kallio H, Uusitalo RJ, Maunuksela EL. Topical anesthesia with or without propofol sedation versus retrobulbar/peribulbar anesthesia for cataract extraction: prospective randomized trial. J Cataract Refract Surg 2001;27(9):1372–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Lim TH, Humayun MS, Yoon YH, et al. The efficacy of retrobulbar block anesthesia only in pars plana vitrectomy and transconjunctival sutureless vitrectomy. Ophthalmic Surg Lasers Imaging 2008;39(3):191–5.PubMedCrossRefGoogle Scholar
  21. 21.
    Quiroz-Mercado H, Garcia-Aguirre G, Ustariz-Gonzalez O, et al. Perfluorocarbon-perfused vitrectomy using a transconjunctival 25-gauge system. Retina 2007;27(7):926–31.PubMedCrossRefGoogle Scholar
  22. 22.
    Quiroz-Mercado H, Rivera-Sempertegui J, Macky TA, et al. Performing vitreous biopsy by perfluorocarbon-perfused vitrectomy. Am J Ophthalmol 2005;140(6):1161–3.PubMedCrossRefGoogle Scholar
  23. 23.
    Quiroz-Mercado H, Guerrero-Naranjo J, Agurto-Rivera R, et al. Perfluorocarbon-perfused vitrectomy: a new method for vitrectomy—a safety and feasibility study. Graefes Arch Clin Exp Ophthalmol 2005;243(6):551–62.PubMedCrossRefGoogle Scholar
  24. 24.
    Quiroz-Mercado H, Suarez-Tata L, Magdalenic R, et al. Perfluorocarbon perfused vitrectomy: animal studies. Am J Ophthalmol 2004;137(2):287–93.PubMedCrossRefGoogle Scholar
  25. 25.
    Huang JS, Russack V, Flores-Aguilar M, et al. Evaluation of cytologic specimens obtained during experimental vitreous biopsy. Retina 1993;13(2):160–5.PubMedCrossRefGoogle Scholar
  26. 26.
    Conlon MR, Craig I, Harris JF, et al. Effect of vitrectomy and cytopreparatory techniques on cell survival and preservation. Can J Ophthalmol 1992;27(4):168–71.PubMedGoogle Scholar
  27. 27.
    Ratanapojnard T, Roy CR, Gariano RF. Effect of vitrector cutting rate on vitreous biopsy yield. Retina 2005;25(6):795–7.PubMedCrossRefGoogle Scholar
  28. 28.
    Van Kuijk FJ, Uwaydatt S, Godley BF. Self-sealing sclerotomies in pars plana vitrectomy. Retina 2001;21:547–50.PubMedCrossRefGoogle Scholar
  29. 29.
    Shields CL, Ganguly A, Materin MA, et al. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases. Trans Am Ophthalmol Soc 2007;105:43–53.PubMedGoogle Scholar
  30. 30.
    Damato B, Groenewald C, McGalliard J, et al. Endoresection of choroidal melanoma. Br J Ophthalmol 1998;82:213–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Whitcup SM, Chan CC, Buggage RR, et al. Improving the diagnostic yield of vitrectomy for intraocular lymphoma. Arch Ophthalmol 2000;118(3):446.PubMedGoogle Scholar
  32. 32.
    Margolis R. Diagnostic vitrectomy for the diagnosis and management of posterior uveitis of unknown etiology. Curr Opin Ophthalmol 2008;19(3):218–24.PubMedCrossRefGoogle Scholar
  33. 33.
    Intzedy L, Teoh SC, Hogan A, et al. Cytopathological analysis of vitreous in intraocular lymphoma. Eye 2008;22(2):289–93.PubMedCrossRefGoogle Scholar
  34. 34.
    Stacchini A, Demurtas A, Godio L, et al. Flow cytometry in the bone marrow staging of mature B-cell neoplasms. Cytometry B Clin Cytom 2003;54:10–8.PubMedCrossRefGoogle Scholar
  35. 35.
    Chan CC, Whitcup SM, Solomon D, et al. Interleukin-10 in the vitreous of patients with primary intraocular lymphoma. Am J Ophthalmol 1995;120(5):671–3.PubMedGoogle Scholar
  36. 36.
    Tritten JJ, Haefliger JM, Delouche D, et al. Interleukin 10 and chronic vitritis in a case of ocular lymphoma [in German]. Klin Monatsbl Augenheilkd 1998;212(5):416–7.PubMedCrossRefGoogle Scholar
  37. 37.
    Akpek EK, Maca SM, Christen WG, et al. Elevated vitreous interleukin-10 level is not diagnostic of intraocular-central nervous system lymphoma. Ophthalmology 1999;106(12):2291–5.PubMedCrossRefGoogle Scholar
  38. 38.
    Wallace DJ, Shen D, Reed GF, et al. Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2006;47(7):2750–6.PubMedCrossRefGoogle Scholar
  39. 39.
    van Dijk MC, Rombout PD, Boots-Sprenger SH, et al. Multiplex ligation-dependent probe amplification for the detection of chromosomal gains and losses in formalin-fixed tissue. Diagn Mol Pathol 2005;14(1):9–16.PubMedCrossRefGoogle Scholar
  40. 40.
    Palexas GN, Green WR, Goldberg MF, et al. Diagnostic pars plana vitrectomy report of a 21-year retrospective study. Trans Am Ophthalmol Soc 1995;93:281–308; discussion 308–14.PubMedGoogle Scholar
  41. 41.
    Zhai J, Harbour JW, Smith ME, et al. Correlation study of benign cytomorphology and final clinical diagnosis. Acta Cytol 2008;52(2):196–200.PubMedCrossRefGoogle Scholar
  42. 42.
    Scott IU, Flynn HW Jr, Dev S, et al. Endophthalmitis after 25-gauge and 20-gauge pars plana vitrectomy: incidence and outcomes. Retina 2008;28(1):138–42.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Garvin H. Davis
    • 1
    Email author
  • Gibran S. Khurshid
    • 2
  • Kapil G. Kapoor
    • 2
  • Bernard F. Godley
    • 2
  1. 1.Department of OphthalmologyThe University of Texas at HoustonHoustonUSA
  2. 2.Department of Ophthalmology and Visual SciencesThe University of Texas Medical BranchGalvestonUSA

Personalised recommendations